Retrospective analysis of treatment for advanced gastric cancer with peritoneal dissemination

Rieko Nakamura, Yoshiro Saikawa, Norihito Wada, Masashi Yoshida, Tetsuro Kubota, Koichiro Kumai, Masaki Kitajima, Yuukou Kitagawa

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Recent development and clinical application of novel anticancer agents like S-1 have been reported to show a good outcome against gastric cancer (GC) with peritoneal dissemination (P). In our study, a retrospective analysis of the treatment for GC with P was performed. Since 1989, a chemosensitivity test with MTT assay (MTTA) using surgical specimen was performed to choose chemotherapy after surgery, resulting in good prognosis in patients who received drugs which were determined effective by the MTTA. Since 1999, S-1 was introduced as adjuvant chemotherapy, and, since 2002, initial treatment with S-1/CDDP was used for GC with P, suggesting a better prognostic outcome compared with previous results with ineffective chemotherapy or surgery alone. In conclusion, prognosis of GC with P has been improving by effective regimens with novel anticancer agents like S-1. Further research and clinical trials will be necessary to achieve a more satisfactory outcome with the treatment of GC with P.

Original languageEnglish
Pages (from-to)1827-1831
Number of pages5
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume34
Issue number11
Publication statusPublished - 2007 Nov

Fingerprint

Stomach Neoplasms
Antineoplastic Agents
Therapeutics
Drug Therapy
Adjuvant Chemotherapy
Clinical Trials
Research
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cancer Research
  • Pharmacology

Cite this

Retrospective analysis of treatment for advanced gastric cancer with peritoneal dissemination. / Nakamura, Rieko; Saikawa, Yoshiro; Wada, Norihito; Yoshida, Masashi; Kubota, Tetsuro; Kumai, Koichiro; Kitajima, Masaki; Kitagawa, Yuukou.

In: Gan to kagaku ryoho. Cancer & chemotherapy, Vol. 34, No. 11, 11.2007, p. 1827-1831.

Research output: Contribution to journalArticle

Nakamura, Rieko ; Saikawa, Yoshiro ; Wada, Norihito ; Yoshida, Masashi ; Kubota, Tetsuro ; Kumai, Koichiro ; Kitajima, Masaki ; Kitagawa, Yuukou. / Retrospective analysis of treatment for advanced gastric cancer with peritoneal dissemination. In: Gan to kagaku ryoho. Cancer & chemotherapy. 2007 ; Vol. 34, No. 11. pp. 1827-1831.
@article{5e90cf400c99443b82d7b46aa5a5f18d,
title = "Retrospective analysis of treatment for advanced gastric cancer with peritoneal dissemination",
abstract = "Recent development and clinical application of novel anticancer agents like S-1 have been reported to show a good outcome against gastric cancer (GC) with peritoneal dissemination (P). In our study, a retrospective analysis of the treatment for GC with P was performed. Since 1989, a chemosensitivity test with MTT assay (MTTA) using surgical specimen was performed to choose chemotherapy after surgery, resulting in good prognosis in patients who received drugs which were determined effective by the MTTA. Since 1999, S-1 was introduced as adjuvant chemotherapy, and, since 2002, initial treatment with S-1/CDDP was used for GC with P, suggesting a better prognostic outcome compared with previous results with ineffective chemotherapy or surgery alone. In conclusion, prognosis of GC with P has been improving by effective regimens with novel anticancer agents like S-1. Further research and clinical trials will be necessary to achieve a more satisfactory outcome with the treatment of GC with P.",
author = "Rieko Nakamura and Yoshiro Saikawa and Norihito Wada and Masashi Yoshida and Tetsuro Kubota and Koichiro Kumai and Masaki Kitajima and Yuukou Kitagawa",
year = "2007",
month = "11",
language = "English",
volume = "34",
pages = "1827--1831",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "11",

}

TY - JOUR

T1 - Retrospective analysis of treatment for advanced gastric cancer with peritoneal dissemination

AU - Nakamura, Rieko

AU - Saikawa, Yoshiro

AU - Wada, Norihito

AU - Yoshida, Masashi

AU - Kubota, Tetsuro

AU - Kumai, Koichiro

AU - Kitajima, Masaki

AU - Kitagawa, Yuukou

PY - 2007/11

Y1 - 2007/11

N2 - Recent development and clinical application of novel anticancer agents like S-1 have been reported to show a good outcome against gastric cancer (GC) with peritoneal dissemination (P). In our study, a retrospective analysis of the treatment for GC with P was performed. Since 1989, a chemosensitivity test with MTT assay (MTTA) using surgical specimen was performed to choose chemotherapy after surgery, resulting in good prognosis in patients who received drugs which were determined effective by the MTTA. Since 1999, S-1 was introduced as adjuvant chemotherapy, and, since 2002, initial treatment with S-1/CDDP was used for GC with P, suggesting a better prognostic outcome compared with previous results with ineffective chemotherapy or surgery alone. In conclusion, prognosis of GC with P has been improving by effective regimens with novel anticancer agents like S-1. Further research and clinical trials will be necessary to achieve a more satisfactory outcome with the treatment of GC with P.

AB - Recent development and clinical application of novel anticancer agents like S-1 have been reported to show a good outcome against gastric cancer (GC) with peritoneal dissemination (P). In our study, a retrospective analysis of the treatment for GC with P was performed. Since 1989, a chemosensitivity test with MTT assay (MTTA) using surgical specimen was performed to choose chemotherapy after surgery, resulting in good prognosis in patients who received drugs which were determined effective by the MTTA. Since 1999, S-1 was introduced as adjuvant chemotherapy, and, since 2002, initial treatment with S-1/CDDP was used for GC with P, suggesting a better prognostic outcome compared with previous results with ineffective chemotherapy or surgery alone. In conclusion, prognosis of GC with P has been improving by effective regimens with novel anticancer agents like S-1. Further research and clinical trials will be necessary to achieve a more satisfactory outcome with the treatment of GC with P.

UR - http://www.scopus.com/inward/record.url?scp=38449107453&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38449107453&partnerID=8YFLogxK

M3 - Article

C2 - 18030017

AN - SCOPUS:38449107453

VL - 34

SP - 1827

EP - 1831

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 11

ER -